Had my first read of the Teva results. Seems like majority of their bad news comes from generic drug for Parkinson's disease. Oncology drugs were up for the trade period. Obviously the generic market competition for Myx is a factor, but not as much as the share price indicates. Will also buy more if it goes to 60c.
Had my first read of the Teva results. Seems like majority of...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.68 |
Change
-0.210(4.29%) |
Mkt cap ! $398.1M | |||
| Open | High | Low | Value | Volume |
| $4.93 | $4.93 | $4.68 | $324.4K | 67.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 535 | $4.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.68 | 4982 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |